{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:12:40Z","timestamp":1791432760388,"version":"4.3.3"},"reference-count":258,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bmc.2021.116356","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:06:39Z","timestamp":1628395599000},"page":"116356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"special_numbering":"C","title":["Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens"],"prefix":"10.1016","volume":"46","author":[{"given":"Supreeti","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravindra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailly","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116356_b0005","unstructured":"Gelderblom HR. Structure and Classification of Viruses. In: Baron S, ed. Galveston (TX); 1996."},{"issue":"24","key":"10.1016\/j.bmc.2021.116356_b0010","article-title":"Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives","volume":"17","author":"Roychoudhury","year":"2020","journal-title":"Int. J. Environ Res. Public Heal"},{"key":"10.1016\/j.bmc.2021.116356_b0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biochi.2018.04.004","article-title":"Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease","volume":"149","author":"Singh","year":"2018","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b0020","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3201\/eid1209.060200","article-title":"Japanese Encephalitis Outbreak, India, 2005","volume":"12","author":"Parida","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bmc.2021.116356_b0025","doi-asserted-by":"crossref","unstructured":"Brathwaite Dick O, San Mart?n JL, Montoya RH, del Diego J, Zambrano B, Dayan GH. The History of Dengue Outbreaks in the Americas. Am Soc Trop Med Hyg. 87(4):584-593. doi:10.4269\/ajtmh.2012.11-0770.","DOI":"10.4269\/ajtmh.2012.11-0770"},{"issue":"7","key":"10.1016\/j.bmc.2021.116356_b0030","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/JLB.4RI1218-503R","article-title":"Unraveling the host\u2019s immune response to infection: Seeing is believing","volume":"106","author":"Scott","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41392-020-0191-1","article-title":"Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2","volume":"5","author":"Catanzaro","year":"2020","journal-title":"Signal Transduct Target Ther."},{"issue":"12","key":"10.1016\/j.bmc.2021.116356_b0045","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.3390\/ijms21124351","article-title":"Host Immune Response and Novel Diagnostic Approach to NTM Infections","volume":"21","author":"Abe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bmc.2021.116356_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.03.008","article-title":"Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review","volume":"83","author":"Chen","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bmc.2021.116356_b0055","doi-asserted-by":"crossref","unstructured":"Fatma B, Kumar R, Singh VA, et al. Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection. Antiviral Res. May 2020:104808. doi:10.1016\/j.antiviral.2020.104808.","DOI":"10.1016\/j.antiviral.2020.104808"},{"key":"10.1016\/j.bmc.2021.116356_b0060","doi-asserted-by":"crossref","unstructured":"Mudgal R, Mahajan S, Tomar S. Inhibition of Chikungunya virus by an adenosine analog targeting the SAM\u2010dependent nsP1 methyltransferase. FEBS Lett. November 2019:1873-3468.13642. doi:10.1002\/1873-3468.13642.","DOI":"10.1002\/1873-3468.13642"},{"issue":"16","key":"10.1016\/j.bmc.2021.116356_b0065","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1080\/07391102.2016.1261046","article-title":"Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease","volume":"35","author":"Dhindwal","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bmc.2021.116356_b0070","doi-asserted-by":"crossref","unstructured":"Tomar S, Aggarwal M. Chapter 5 - Structure and Function of Alphavirus Proteases. In: Gupta SPBT-VP and TI, ed. Academic Press; 2017:105-135. doi:https:\/\/doi.org\/10.1016\/B978-0-12-809712-0.00005-8.","DOI":"10.1016\/B978-0-12-809712-0.00005-8"},{"key":"10.1016\/j.bmc.2021.116356_b0075","doi-asserted-by":"crossref","unstructured":"Kielian M, Chatterjee PK, Gibbons DL, Lu YE. Specific Roles for Lipids in Virus Fusion and Exit Examples from the Alphaviruses BT - Fusion of Biological Membranes and Related Problems. In: Hilderson H, Fuller S, eds. Boston, MA: Springer US; 2002:409-455. doi:10.1007\/0-306-46824-7_11.","DOI":"10.1007\/0-306-46824-7_11"},{"key":"10.1016\/j.bmc.2021.116356_b0080","doi-asserted-by":"crossref","unstructured":"Zhang S, Xin F, Zhang X. The compound packaged in virions is the key to trigger host glycolysis machinery for virus life cycle in the cytoplasm. iScience. 2021;24(1):101915. doi:https:\/\/doi.org\/10.1016\/j.isci.2020.101915.","DOI":"10.1016\/j.isci.2020.101915"},{"key":"10.1016\/j.bmc.2021.116356_b0085","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.2147\/IDR.S262024","article-title":"Targeting Polyamine Metabolism for Control of Human Viral Diseases","volume":"13","author":"Huang","year":"2020","journal-title":"Infect Drug Resist."},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124792","article-title":"The Ubiquitin Proteasome System Plays a Role in Venezuelan Equine Encephalitis Virus Infection","volume":"10","author":"Amaya","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2021.116356_b0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61552","article-title":"Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration","volume":"9","author":"Yang","year":"2020","journal-title":"Elife."},{"key":"10.1016\/j.bmc.2021.116356_b0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cytogfr.2020.04.002","article-title":"Cytokine storm intervention in the early stages of COVID-19 pneumonia","volume":"53","author":"Sun","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bmc.2021.116356_b0105","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.csbj.2021.06.015","article-title":"Programmed \u22121 ribosomal frameshifting from the perspective of the conformational dynamics of mRNA and ribosomes","volume":"19","author":"Chang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat Rev Drug Discov."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0115","first-page":"e00168","article-title":"Host-Directed Antiviral Therapy","volume":"33","author":"Naveen","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/ph14040332","article-title":"Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico\/In Vitro Screening Methods","volume":"14","author":"Ginex","year":"2021","journal-title":"Pharmaceuticals (Basel)."},{"key":"10.1016\/j.bmc.2021.116356_b0125","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3389\/fimmu.2020.01664","article-title":"Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach","volume":"11","author":"Choudhary","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bmc.2021.116356_b0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2018.10.009","article-title":"Glycan-dependent chikungunya viral infection divulged by antiviral activity of NAG specific chi-like lectin","volume":"526","author":"Kaur","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.bmc.2021.116356_b0135","doi-asserted-by":"crossref","unstructured":"V\u2019kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155-170. doi:10.1038\/s41579-020-00468-6.","DOI":"10.1038\/s41579-020-00468-6"},{"key":"10.1016\/j.bmc.2021.116356_b0140","doi-asserted-by":"crossref","unstructured":"Rani R, Singh A, Pareek A, Tomar S. In silico guided drug repurposing to combat SARS-CoV-2 by Targeting Mpro, the key virus specific protease. 2020.","DOI":"10.26434\/chemrxiv.12030345.v1"},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b0145","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1873-3468.13642","article-title":"Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase","volume":"594","author":"Mudgal","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bmc.2021.116356_b0150","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez E, Murillo A, Vel\u00e1zquez R, Burnham A, Arias CF. Replication Cycle of Astroviruses. Schultz-Cherry S, ed. Astrovirus Res Essent Ideas, Everyday Impacts, Futur Dir. September 2012:19-45. doi:10.1007\/978-1-4614-4735-1_2.","DOI":"10.1007\/978-1-4614-4735-1_2"},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1437","article-title":"Organization of the Flavivirus RNA replicase complex","volume":"8","author":"Brand","year":"2017","journal-title":"WIREs RNA"},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b0160","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chom.2009.04.001","article-title":"Pathogenesis of Flavivirus Infections: Using and Abusing the Host Cell","volume":"5","author":"Fernandez-Garcia","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bmc.2021.116356_b0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2015.06.017","article-title":"Towards antivirals against chikungunya virus","volume":"121","author":"Abdelnabi","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bmc.2021.116356_b0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.coviro.2017.03.016","article-title":"Chikungunya virus infections: time to act, time to treat","volume":"24","author":"Abdelnabi","year":"2017","journal-title":"Curr Opin Virol."},{"issue":"8","key":"10.1016\/j.bmc.2021.116356_b0175","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jgm.929","article-title":"RNA interference for antiviral therapy","volume":"8","author":"Ketzinel-Gilad","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bmc.2021.116356_b0180","doi-asserted-by":"crossref","unstructured":"Bean B. Antiviral therapy: current concepts and practices. Clin Microbiol Rev. 1992;5(2):146 LP - 182. doi:10.1128\/CMR.5.2.146.","DOI":"10.1128\/CMR.5.2.146"},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/hep.23733","article-title":"Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro","volume":"52","author":"Woodhouse","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nchembio.2050","article-title":"Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification","volume":"12","author":"Deans","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12053","article-title":"RNA-based mechanisms regulating host\u2013virus interactions","volume":"253","author":"Zhou","year":"2013","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/ph6020124","article-title":"siRNA Genome Screening Approaches to Therapeutic Drug Repositioning","volume":"6","author":"Perwitasari","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bmc.2021.116356_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.aivir.2015.11.001","article-title":"Functional Genomic Strategies for Elucidating Human-Virus Interactions: Will CRISPR Knockout RNAi and Haploid Cells?","volume":"94","author":"Perreira","year":"2016","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.bmc.2021.116356_b0210","doi-asserted-by":"crossref","unstructured":"Lu G, Hideki A, Jian-Wen H, C. LMM. Interactions between Viral Nonstructural Proteins and Host Protein hVAP-33 Mediate the Formation of Hepatitis C Virus RNA Replication Complex on Lipid Raft. J Virol. 2004;78(7):3480-3488. doi:10.1128\/JVI.78.7.3480-3488.2004.","DOI":"10.1128\/JVI.78.7.3480-3488.2004"},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b0215","first-page":"1341","article-title":"Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection","volume":"151","author":"Rottman","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0220","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230844","article-title":"Metabolic changes during respiratory syncytial virus infection of epithelial cells","volume":"15","author":"Mart\u00edn-Vicente","year":"2020","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s11658-020-00211-2","article-title":"Metabolic host response and therapeutic approaches to influenza infection","volume":"25","author":"Keshavarz","year":"2020","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0235","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/s22010303","article-title":"The Role of Lipid Metabolism in Influenza A Virus Infection","volume":"10","author":"Zhou","year":"2021","journal-title":"Pathog (Basel, Switzerland)."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/v13030369","article-title":"The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses","volume":"13","author":"Valerdi","year":"2021","journal-title":"Viruses."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0245","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1128\/JVI.79.1.644-648.2005","article-title":"The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry","volume":"79","author":"Yu","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0250","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41467-017-02816-2","article-title":"An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction","volume":"9","author":"Xia","year":"2018","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.bmc.2021.116356_b0255","doi-asserted-by":"crossref","first-page":"e00344","DOI":"10.1128\/JVI.00344-17","article-title":"Chikungunya Virus Overcomes Polyamine Depletion by Mutation of nsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness","volume":"91","author":"Mounce","year":"2017","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/CS20201042","article-title":"Host cell glutamine metabolism as a potential antiviral target","volume":"135","author":"Hirabara","year":"2021","journal-title":"Clin. Sci."},{"issue":"11","key":"10.1016\/j.bmc.2021.116356_b0265","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.116.309866","article-title":"AXL-Mediated Productive Infection of Human Endothelial Cells by Zika Virus","volume":"119","author":"Liu","year":"2016","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0270","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.celrep.2016.12.068","article-title":"Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus","volume":"18","author":"Rausch","year":"2017","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"21","key":"10.1016\/j.bmc.2021.116356_b0280","first-page":"9683","article-title":"Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses","volume":"90","author":"Mb","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.bmc.2021.116356_b0285","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2017.04.016","article-title":"Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles","volume":"143","author":"Albulescu","year":"2017","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0290","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1\u2013like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat. Med."},{"issue":"Suppl 2","key":"10.1016\/j.bmc.2021.116356_b0295","doi-asserted-by":"crossref","first-page":"S553","DOI":"10.1016\/S0168-8278(12)61416-0","article-title":"Alisporivir plus ribavirin is highly effective as interferon-free or interferon-add-on regimen in previously untreated HCV-G2 or G3 patients: SVR12 results from VITAL-1 phase 2b study","volume":"56","author":"Pawlotsky","year":"2012","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0300","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.coviro.2011.10.030","article-title":"Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action","volume":"1","author":"Paeshuyse","year":"2011","journal-title":"Curr Opin Virol."},{"issue":"7816","key":"10.1016\/j.bmc.2021.116356_b0305","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0310","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11481-009-9158-2","article-title":"Curcumin Protects Neuronal Cells from Japanese Encephalitis Virus-Mediated Cell Death and also Inhibits Infective Viral Particle Formation by Dysregulation of Ubiquitin-Proteasome System","volume":"4","author":"Dutta","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bmc.2021.116356_b0315","unstructured":"CuraChik\u00a0: A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00391313?cond=chikungunya&draw=2&rank=14. Accessed June 30, 2021."},{"issue":"21","key":"10.1016\/j.bmc.2021.116356_b0320","first-page":"9743","article-title":"The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling","volume":"90","author":"Vf","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.bmc.2021.116356_b0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2013.12.010","article-title":"Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivo","volume":"103","author":"Rathore","year":"2014","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0330","doi-asserted-by":"crossref","first-page":"11320","DOI":"10.1038\/ncomms11320","article-title":"A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs","volume":"7","author":"Karlas","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bmc.2021.116356_b0335","unstructured":"Ivermectin in Adults With Severe COVID-19. - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04602507. Accessed July 1, 2021."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0340","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1038\/s41598-019-43030-y","article-title":"Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B","volume":"9","author":"Warfield","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092100","article-title":"Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?","volume":"9","author":"Jans","year":"2020","journal-title":"Cells."},{"issue":"8","key":"10.1016\/j.bmc.2021.116356_b0350","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","article-title":"Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): A phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial","volume":"14","author":"Low","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bmc.2021.116356_b0355","unstructured":"Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04673422?cond=dengue&draw=8&rank=123. Accessed July 1, 2021."},{"issue":"10","key":"10.1016\/j.bmc.2021.116356_b0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060270","article-title":"Seeking Membranes: Positive-Strand RNA Virus Replication Complexes","volume":"6","author":"Denison","year":"2008","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0365","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1074\/jbc.M110.198002","article-title":"Envelope Lipid-packing as a Critical Factor for the Biological Activity and Stability of Alphavirus Particles Isolated from Mammalian and Mosquito Cells *","volume":"286","author":"Sousa","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bmc.2021.116356_b0370","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.15252\/embj.201490315","article-title":"Lipid droplets and their component triglycerides and steryl esters regulate autophagosome biogenesis","volume":"34","author":"Shpilka","year":"2015","journal-title":"EMBO J."},{"issue":"14","key":"10.1016\/j.bmc.2021.116356_b0375","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/PL00000836","article-title":"Sphingolipids in mammalian cell signalling","volume":"58","author":"Ohanian","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"issue":"13","key":"10.1016\/j.bmc.2021.116356_b0380","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1128\/JVI.00117-08","article-title":"Cholesterol effectively blocks entry of flavivirus","volume":"82","author":"Lee","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bmc.2021.116356_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104642","article-title":"Fatty acid synthase and stearoyl-CoA desaturase-1 are conserved druggable cofactors of Old World Alphavirus genome replication","volume":"172","author":"Bakhache","year":"2019","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0390","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm820","article-title":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors","volume":"9","author":"Joseph","year":"2003","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0395","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.coviro.2012.09.006","article-title":"(+)RNA viruses rewire cellular pathways to build replication organelles","volume":"2","author":"Belov","year":"2012","journal-title":"Curr Opin Virol."},{"key":"10.1016\/j.bmc.2021.116356_b0400","doi-asserted-by":"crossref","unstructured":"Heaton NS, Perera R, Berger KL, et al. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci. 2010;107(40):17345 LP - 17350. doi:10.1073\/pnas.1010811107.","DOI":"10.1073\/pnas.1010811107"},{"key":"10.1016\/j.bmc.2021.116356_b0405","article-title":"Contemporary Strategies and Current Trends in Designing Antiviral Drugs against Dengue Fever via Targeting Host-Based Approaches","author":"Ahammad","year":"201979296","journal-title":"Microorganisms."},{"key":"10.1016\/j.bmc.2021.116356_b0410","unstructured":"Gullberg R. Flavivirus control of lipid metabolism: implications for virion formation, function and pathogenesis. Dissertation. doi:https:\/\/hdl.handle.net\/10217\/191407."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0415","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1471-4159.2010.06951.x","article-title":"Critical role of lipid rafts in virus entry and activation of phosphoinositide 3\u2032 kinase\/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem\/progenitor cells","volume":"115","author":"Das","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bmc.2021.116356_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107750","article-title":"A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor","volume":"221","author":"Oz","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0425","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1038\/s41467-020-19883-7","article-title":"SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication","volume":"11","author":"Alexandersen","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b0430","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000510508","article-title":"Switching Host Metabolism as an Approach to Dampen SARS-CoV-2 Infection","volume":"76","author":"Soliman","year":"2020","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.bmc.2021.116356_b0435","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biochi.2020.10.010","article-title":"Membrane heist: Coronavirus host membrane remodeling during replication","volume":"179","author":"Zhang","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.bmc.2021.116356_b0440","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coviro.2016.09.003","article-title":"The quest for host targets to combat dengue virus infections","volume":"20","author":"Acosta","year":"2016","journal-title":"Curr Opin Virol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0445","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/AAC.01578-15","article-title":"Modification of the Host Cell Lipid Metabolism Induced by Hypolipidemic Drugs Targeting the Acetyl Coenzyme A Carboxylase Impairs West Nile Virus Replication","volume":"60","author":"Merino-Ramos","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0450","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/13543776.2020.1751817","article-title":"Antiviral therapeutics for chikungunya virus","volume":"30","author":"Ghildiyal","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0455","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2013.03.005","article-title":"Requirement of cholesterol in the viral envelope for dengue virus infection","volume":"174","author":"Carro","year":"2013","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0460","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/s41598-017-03316-5","article-title":"Imipramine Inhibits Chikungunya Virus Replication in Human Skin Fibroblasts through Interference with Intracellular Cholesterol Trafficking","volume":"7","author":"Wichit","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b0465","doi-asserted-by":"crossref","first-page":"e01220","DOI":"10.1128\/AAC.01220-19","article-title":"Inhibition of Chikungunya Virus Replication in Primary Human Fibroblasts by Liver X Receptor Agonist","volume":"63","author":"Hwang","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"19","key":"10.1016\/j.bmc.2021.116356_b0470","doi-asserted-by":"crossref","first-page":"19970","DOI":"10.1074\/jbc.M402165200","article-title":"C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase*","volume":"279","author":"Kim","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0475","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3892\/mmr.2016.5519","article-title":"The anti-dengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression","volume":"14","author":"Bryan-Marrugo Lloyd","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0480","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2011.11.014","article-title":"U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication","volume":"93","author":"Poh","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bmc.2021.116356_b0485","article-title":"Indirect Acting Antivirals; Tricking the Virus through a Pristine Approach","author":"Aqeel","year":"2017","journal-title":"In"},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b0490","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2007.09.003","article-title":"Cholesterol Manipulation by West Nile Virus Perturbs the Cellular Immune Response","volume":"2","author":"Mackenzie","year":"2007","journal-title":"Cell Host Microbe"},{"issue":"8","key":"10.1016\/j.bmc.2021.116356_b0495","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1139\/cjm-2015-0292","article-title":"Armand-Frappier Outstanding Student Award \u2014 The emerging role of 25-hydroxycholesterol in innate immunity","volume":"61","author":"Singaravelu","year":"2015","journal-title":"Can. J. Microbiol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0500","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000213504","article-title":"An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads","volume":"52","author":"Sezaki","year":"2009","journal-title":"Intervirology"},{"key":"10.1016\/j.bmc.2021.116356_b0505","unstructured":"Milad Biparva N. UJEMI PEARLS Use of Combinational Broad-Spectrum Antiviral Cocktail for Treating Current and Emerging Coronavirus Infections. Vol 4.; 2020. https:\/\/jemi.microbiology.ubc.ca\/. Accessed May 2, 2021."},{"key":"10.1016\/j.bmc.2021.116356_b0510","article-title":"Lipid Metabolism as a Source of Druggable Targets for Antiviral Discovery against Zika and Other Flaviviruses","author":"Mart\u00edn-Acebes","year":"201912297","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0515","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41598-020-58468-8","article-title":"Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus","volume":"10","author":"Hitakarun","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bmc.2021.116356_b0520","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tvjl.2017.10.009","article-title":"Differential effects of lipid biosynthesis inhibitors on Zika and Semliki Forest viruses","volume":"230","author":"Royle","year":"2017","journal-title":"Vet. J."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0525","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0042-6822(91)90119-V","article-title":"Synthesis of Semliki Forest virus RNA requires continuous lipid synthesis","volume":"183","author":"Perez","year":"1991","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b0530","first-page":"1365","volume":"8","author":"Abdelnabi","year":"2020","journal-title":"Antiviral Strategies against Arthritogenic Alphaviruses. Microorganisms."},{"issue":"12","key":"10.1016\/j.bmc.2021.116356_b0535","doi-asserted-by":"crossref","DOI":"10.3390\/v12121356","article-title":"Valproic Acid and Its Amidic Derivatives as New Antivirals against Alphaherpesviruses","volume":"12","author":"Andreu","year":"2020","journal-title":"Viruses."},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b0540","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.chom.2014.10.003","article-title":"Rhinovirus Uses a Phosphatidylinositol 4-Phosphate\/Cholesterol Counter-Current for the Formation of Replication Compartments at the ER-Golgi Interface","volume":"16","author":"Roulin","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0545","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.micro.56.012302.160757","article-title":"Poliovirus Cell Entry: Common Structural Themes in Viral Cell Entry Pathways","volume":"56","author":"Hogle","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.bmc.2021.116356_b0550","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.numecd.2020.05.003","article-title":"May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?","volume":"30","author":"Scicali","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"10.1016\/j.bmc.2021.116356_b0555","doi-asserted-by":"crossref","unstructured":"Silvas JA, Jureka AS, Nicolini AM, Chvatal SA, Basler CF. Inhibitors of VPS34 and lipid metabolism suppress SARS-CoV-2 replication. bioRxiv. January 2020:2020.07.18.210211. doi:10.1101\/2020.07.18.210211.","DOI":"10.1101\/2020.07.18.210211"},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0560","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020473","article-title":"Metabolic Reprogramming of Host Cells in Response to Enteroviral Infection","volume":"9","author":"Cheng","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.bmc.2021.116356_b0565","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fcimb.2019.00095","article-title":"Virus Control of Cell Metabolism for Replication and Evasion of Host Immune Responses","volume":"9","author":"Moreno-Altamirano","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bmc.2021.116356_b0570","doi-asserted-by":"crossref","unstructured":"Vander Heiden MG, Locasale JW, Swanson KD, et al. Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells. Science (80-). 2010;329(5998):1492 LP - 1499. doi:10.1126\/science.1188015.","DOI":"10.1126\/science.1188015"},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0575","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/10409238.2013.844093","article-title":"Stress eating and tuning out: Cancer cells re-wire metabolism to counter stress","volume":"48","author":"Stine","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"6311","key":"10.1016\/j.bmc.2021.116356_b0580","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000719","article-title":"Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics","volume":"6","author":"Diamond","year":"2010","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0590","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20210003","article-title":"Pathogens Hijack Host Cell Metabolism: Intracellular Infection as a Driver of the Warburg Effect in Cancer and Other Chronic Inflammatory Conditions","volume":"3","author":"Proal","year":"2021","journal-title":"Immunometabolism."},{"issue":"7","key":"10.1016\/j.bmc.2021.116356_b0595","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tim.2011.04.002","article-title":"Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection","volume":"19","author":"Yu","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bmc.2021.116356_b0600","doi-asserted-by":"crossref","unstructured":"Codo AC, Davanzo GG, Monteiro L de B, et al. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α\/Glycolysis-Dependent Axis. Cell Metab. 2020;32(3):437-446.e5. doi:10.1016\/j.cmet.2020.07.007.","DOI":"10.2139\/ssrn.3606770"},{"key":"10.1016\/j.bmc.2021.116356_b0605","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biochi.2020.11.010","article-title":"The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response","volume":"180","author":"Icard","year":"2021","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b0610","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.xphs.2016.05.012","article-title":"A Minireview: Usefulness of Transporter-Targeted Prodrugs in Enhancing Membrane Permeability","volume":"105","author":"Murakami","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bmc.2021.116356_b0615","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2020.07.009","article-title":"Recent advances in antiviral drug development towards dengue virus","volume":"43","author":"Troost","year":"2020","journal-title":"Curr Opin Virol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0620","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-021-00532-4","article-title":"Targeting glucose metabolism for treatment of COVID-19","volume":"6","author":"Ardestani","year":"2021","journal-title":"Signal Transduct Target Ther."},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b0625","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.cmet.2019.01.024","article-title":"Differential Metabolic Reprogramming by Zika Virus Promotes Cell Death in Human versus Mosquito Cells","volume":"29","author":"Thaker","year":"2019","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0630","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijantimicag.2019.03.017","article-title":"Phloretin inhibits Zika virus infection by interfering with cellular glucose utilisation","volume":"54","author":"Lin","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"11","key":"10.1016\/j.bmc.2021.116356_b0635","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.drudis.2018.06.014","article-title":"The A-Z of Zika drug discovery","volume":"23","author":"Mottin","year":"2018","journal-title":"Drug Discov Today."},{"key":"10.1016\/j.bmc.2021.116356_b0640","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3650499","article-title":"The SARS-CoV-2 Transcriptional Metabolic Signature in Lung Epithelium","author":"Ehrlich","year":"2020","journal-title":"SSRN Electron J."},{"key":"10.1016\/j.bmc.2021.116356_b0645","article-title":"Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2?","volume":"131","author":"Mansouri","year":"2020","journal-title":"A scientific rational. Biomed Pharmacother."},{"key":"10.1016\/j.bmc.2021.116356_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173448","article-title":"In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2","volume":"886","author":"Vijayakumar","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0655","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3892\/ijmm.2020.4608","article-title":"Comprehensive analysis of drugs to treat SARS-CoV-2 infection: Mechanistic insights into current COVID-19 therapies (Review)","volume":"46","author":"Nitulescu","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0660","first-page":"1","article-title":"Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac","volume":"9","author":"Chiow","year":"2016","journal-title":"J Trop Med."},{"key":"10.1016\/j.bmc.2021.116356_b0665","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.antiviral.2017.03.026","article-title":"Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin","volume":"143","author":"Peng","year":"2017","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0670","doi-asserted-by":"crossref","first-page":"11421","DOI":"10.1038\/srep11421","article-title":"Antiviral activity of silymarin against chikungunya virus","volume":"5","author":"Lani","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0675","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0968-0896(01)00275-9","article-title":"Antimicrobial and Anti-Lipase Activity of Quercetin and its C2\u2013C16 3-O-Acyl-Esters","volume":"10","author":"Gatto","year":"2002","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0680","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22020191","article-title":"Silymarin\/Silybin and Chronic Liver Disease: A Marriage of Many Years","volume":"22","author":"Federico","year":"2017","journal-title":"Mol."},{"issue":"16","key":"10.1016\/j.bmc.2021.116356_b0685","doi-asserted-by":"crossref","first-page":"11836","DOI":"10.1074\/jbc.M610106200","article-title":"p21-activated Kinase 1 Is Activated through the Mammalian Target of Rapamycin\/p70 S6 Kinase Pathway and Regulates the Replication of Hepatitis C Virus in Human Hepatoma Cells*","volume":"282","author":"Ishida","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bmc.2021.116356_b0690","doi-asserted-by":"crossref","DOI":"10.3390\/v9110322","article-title":"Hijacking of the Ubiquitin\/Proteasome Pathway by the HIV Auxiliary Proteins","volume":"9","author":"Seissler","year":"2017","journal-title":"Viruses."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0695","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1097-2765(01)00347-1","article-title":"Ubiquitin Enters the New Millennium","volume":"8","author":"Pickart","year":"2001","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0700","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cbpa.2004.09.009","article-title":"Polyubiquitin chains: polymeric protein signals","volume":"8","author":"Pickart","year":"2004","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"8","key":"10.1016\/j.bmc.2021.116356_b0705","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrm1700","article-title":"Ubiquitin and ubiquitin-like proteins as multifunctional signals","volume":"6","author":"Welchman","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0710","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.chom.2009.05.012","article-title":"Ubiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection","volume":"5","author":"Isaacson","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bmc.2021.116356_b0715","article-title":"Cycles of ubiquitination and deubiquitination critically regulate growth factor-mediated activation of Akt signaling","author":"Yang","year":"201362573","journal-title":"Sci Signal."},{"issue":"7825","key":"10.1016\/j.bmc.2021.116356_b0720","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41586-020-2457-8","article-title":"Envelope protein ubiquitination drives entry and pathogenesis of Zika virus","volume":"585","author":"Giraldo","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0725","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.celrep.2018.04.013","article-title":"TIM-1 Ubiquitination Mediates Dengue Virus Entry","volume":"23","author":"Dejarnac","year":"2018","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003265","article-title":"Dengue Virus Co-opts UBR4 to Degrade STAT2 and Antagonize Type I Interferon Signaling","volume":"9","author":"Morrison","year":"2013","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.bmc.2021.116356_b0735","article-title":"Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors","volume":"13","author":"Petushkova","year":"2020","journal-title":"Opportunities, and Limitations. Pharm."},{"issue":"7835","key":"10.1016\/j.bmc.2021.116356_b0740","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.bmc.2021.116356_b0745","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1128\/JVI.00541-12","article-title":"Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II","volume":"86","author":"Akhrymuk","year":"2012","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b0750","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/v11040370","article-title":"A Functional Ubiquitin-Proteasome System is Required for Efficient Replication of New World Mayaro and Una Alphaviruses","volume":"11","author":"Llamas-Gonz\u00e1lez","year":"2019","journal-title":"Viruses."},{"issue":"7","key":"10.1016\/j.bmc.2021.116356_b0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002585","article-title":"Ubiquitination Is Required for Effective Replication of Coxsackievirus B3","volume":"3","author":"Si","year":"2008","journal-title":"PLoS ONE"},{"issue":"22","key":"10.1016\/j.bmc.2021.116356_b0760","doi-asserted-by":"crossref","first-page":"11964","DOI":"10.1128\/JVI.05286-11","article-title":"Replication of the rotavirus genome requires an active ubiquitin-proteasome system","volume":"85","author":"L\u00f3pez","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.bmc.2021.116356_b0765","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antiviral Res."},{"issue":"18","key":"10.1016\/j.bmc.2021.116356_b0770","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106275","article-title":"Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2","volume":"39","author":"Klemm","year":"2020","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0775","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Osipiuk","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0780","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1743-422X-7-214","article-title":"Upregulation of a novel eukaryotic translation initiation factor 5A (eIF5A) in dengue 2 virus-infected mosquito cells","volume":"7","author":"Shih","year":"2010","journal-title":"Virol J."},{"key":"10.1016\/j.bmc.2021.116356_b0785","doi-asserted-by":"crossref","unstructured":"Luna-Rojas L, Avila-Trejo AM, Alc\u00e1ntara-Farf\u00e1n V, Rodr\u00edguez-P\u00e1ez LI, Pastor-Alonso MO, Aguilar-Faisal JL. Antiviral activity of N-\u03c9-Chloroacetyl-L-Ornithine on in vitro replication of Chikungunya virus. bioRxiv. January 2019:745455. doi:10.1101\/745455.","DOI":"10.1101\/745455"},{"key":"10.1016\/j.bmc.2021.116356_b0790","doi-asserted-by":"crossref","unstructured":"C. MB, E. OM, Marco V, H. CJ. Polyamines and Their Role in Virus Infection. Microbiol Mol Biol Rev. 2021;81(4):e00029-17. doi:10.1128\/MMBR.00029-17.","DOI":"10.1128\/MMBR.00029-17"},{"key":"10.1016\/j.bmc.2021.116356_b0795","article-title":"Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry","author":"Firpo","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"10","key":"10.1016\/j.bmc.2021.116356_b0800","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.celrep.2019.07.099","article-title":"Ribavirin Induces Polyamine Depletion via Nucleotide Depletion to Limit Virus Replication","volume":"28","author":"Tate","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bmc.2021.116356_b0805","doi-asserted-by":"crossref","unstructured":"Huelgas-Morales G, Silva-Garc\u00eda CG, Salinas LS, Greenstein D, Navarro RE. The Stress Granule RNA-Binding Protein TIAR-1 Protects Female Germ Cells from Heat Shock in <em>Caenorhabditis elegans<\/em> G3 Genes|Genomes|Genetics. 2016;6(4):1031 LP - 1047. doi:10.1534\/g3.115.026815.","DOI":"10.1534\/g3.115.026815"},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b0810","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tim.2012.02.001","article-title":"Regulation of stress granules in virus systems","volume":"20","author":"White","year":"2012","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0815","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41467-020-20768-y","article-title":"The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein","volume":"12","author":"Lu","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2010.10.009","article-title":"Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells","volume":"89","author":"Khan","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bmc.2021.116356_b0825","doi-asserted-by":"crossref","unstructured":"Emara MM, Brinton MA. Interaction of TIA-1\/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly. Proc Natl Acad Sci. 2007;104(21):9041 LP - 9046. doi:10.1073\/pnas.0703348104.","DOI":"10.1073\/pnas.0703348104"},{"key":"10.1016\/j.bmc.2021.116356_b0830","doi-asserted-by":"crossref","unstructured":"Hou S, Kumar A, Xu Z, et al. Zika Virus Hijacks Stress Granule Proteins and Modulates the Host Stress Response. Diamond MS, ed. J Virol. 2017;91(16):e00474-17. doi:10.1128\/JVI.00474-17.","DOI":"10.1128\/JVI.00474-17"},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0835","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/wrna.1162","article-title":"Regulation of stress granules and P-bodies during RNA virus infection","volume":"4","author":"Lloyd","year":"2013","journal-title":"Wiley Interdiscip Rev RNA."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0840","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004659","article-title":"Viral and Cellular Proteins Containing FGDF Motifs Bind G3BP to Block Stress Granule Formation","volume":"11","author":"Panas","year":"2015","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.bmc.2021.116356_b0845","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160078","article-title":"Combined structural, biochemical and cellular evidence demonstrates that both FGDF motifs in alphavirus nsP3 are required for efficient replication","volume":"6","author":"Schulte","year":"2021","journal-title":"Open Biol."},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b0850","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/JVI.06501-11","article-title":"Hsp70 Protein Positively Regulates Rabies Virus Infection","volume":"86","author":"Xavier","year":"2012","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b0855","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.cell.2015.10.046","article-title":"Defining Hsp70 Subnetworks in Dengue Virus Replication Reveals Key Vulnerability in Flavivirus Infection","volume":"163","author":"Taguwa","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b0860","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075188","article-title":"Heat Shock Protein 70 Is Associated with Replicase Complex of Japanese Encephalitis Virus and Positively Regulates Viral Genome Replication","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0865","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/22221751.2018.1557988","article-title":"Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication, and egress from host cells","volume":"8","author":"Pujhari","year":"2019","journal-title":"Emerg Microbes Infect."},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b0870","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.celrep.2018.12.095","article-title":"Zika Virus Dependence on Host Hsp70 Provides a Protective Strategy against Infection and Disease","volume":"26","author":"Taguwa","year":"2019","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b0875","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1128\/JVI.03077-15","article-title":"Chaperone-Assisted Protein Folding Is Critical for Yellow Fever Virus NS3\/4A Cleavage and Replication","volume":"90","author":"Bozzacco","year":"2016","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b0880","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2893.2011.01556.x","article-title":"Nonstructural 5A protein of hepatitis C virus regulates heat shock protein 72 for its own propagation","volume":"19","author":"Lim","year":"2012","journal-title":"J Viral Hepat."},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b0885","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jmv.20786","article-title":"Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70","volume":"79","author":"Cabrera-Hernandez","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bmc.2021.116356_b0890","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2016.03.017","article-title":"An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target","volume":"130","author":"Howe","year":"2016","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0895","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2018.12.030","article-title":"Regulation of HIV-1 Gag-Pol Expression by Shiftless, an Inhibitor of Programmed -1 Ribosomal Frameshifting","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2021.116356_b0900","first-page":"LP-E2181","article-title":"Transactivation of programmed ribosomal frameshifting by a viral protein","author":"Li","year":"2014111212172","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0905","first-page":"e01766","article-title":"Ablation of Programmed \u22121 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity","volume":"91","author":"Kj","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.bmc.2021.116356_b0910","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biochi.2015.02.007","article-title":"Mechanisms of mRNA frame maintenance and its subversion during translation of the genetic code","volume":"114","author":"Dunkle","year":"2015","journal-title":"Biochimie"},{"issue":"30","key":"10.1016\/j.bmc.2021.116356_b0915","doi-asserted-by":"crossref","first-page":"15788","DOI":"10.1074\/jbc.M116.735613","article-title":"Structural and Functional Characterization of Programmed Ribosomal Frameshift Signals in West Nile Virus Strains Reveals High Structural Plasticity Among cis-Acting RNA Elements*","volume":"291","author":"Moomau","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.bmc.2021.116356_b0920","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023051118","article-title":"Restriction of SARS-CoV-2 replication by targeting programmed \u22121 ribosomal frameshifting","volume":"118","author":"Sun","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2011.04.009","article-title":"Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication","volume":"91","author":"Ahn","year":"2011","journal-title":"Antiviral Res."},{"issue":"45","key":"10.1016\/j.bmc.2021.116356_b0930","doi-asserted-by":"crossref","first-page":"17536","DOI":"10.1074\/jbc.RA118.005606","article-title":"Functional and structural characterization of the chikungunya virus translational recoding signals","volume":"293","author":"Kendra","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2021.116356_b0935","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.coviro.2020.06.005","article-title":"Revisiting an old friend: new findings in alphavirus structure and assembly","volume":"45","author":"Button","year":"2020","journal-title":"Curr Opin Virol."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0940","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/JVI.01979-09","article-title":"NS1\u2032 of Flaviviruses in the Japanese Encephalitis Virus Serogroup Is a Product of Ribosomal Frameshifting and Plays a Role in Viral Neuroinvasiveness","volume":"84","author":"Balmori","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.bmc.2021.116356_b0945","doi-asserted-by":"crossref","unstructured":"Bhatt PR, Scaiola A, Loughran G, et al. Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome. Science (80-). 2021;372(6548):1306 LP - 1313. doi:10.1126\/science.abf3546.","DOI":"10.1126\/science.abf3546"},{"issue":"31","key":"10.1016\/j.bmc.2021.116356_b0950","doi-asserted-by":"crossref","first-page":"10741","DOI":"10.1074\/jbc.AC120.013449","article-title":"Structural and functional conservation of the programmed \u22121 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2)","volume":"295","author":"Kelly","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b0955","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41564-020-00846-z","article-title":"The SARS-CoV-2 RNA\u2013protein interactome in infected human cells","volume":"6","author":"Schmidt","year":"2021","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0960","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11894-002-0034-y","article-title":"Treatment of chronic hepatitis C with PEGylated interferon and ribavirin","volume":"4","author":"Cornberg","year":"2002","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"56","key":"10.1016\/j.bmc.2021.116356_b0965","doi-asserted-by":"crossref","first-page":"13875","DOI":"10.1002\/chem.201702999","article-title":"Design, Synthesis, and Characterization of Brequinar Conjugates as Probes to Study DHODH Inhibition","volume":"23","author":"Madak","year":"2017","journal-title":"Chem \u2013 A Eur J."},{"issue":"22","key":"10.1016\/j.bmc.2021.116356_b0970","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1021\/bi00563a010","article-title":"Inhibition of orotidine-5\u2019-phosphate decarboxylase by 1-(5\u2019-phospho-.beta.-D-ribofuranosyl)barbituric acid, 6-azauridine 5\u2019-phosphate, and uridine 5\u2019-phosphate","volume":"19","author":"Levine","year":"1980","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b0975","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2003.09.005","article-title":"In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-\u03b1 and ribavirin combination","volume":"61","author":"Briolant","year":"2004","journal-title":"Antiviral Res."},{"issue":"7","key":"10.1016\/j.bmc.2021.116356_b0980","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrmicro.2016.60","article-title":"Opportunistic intruders: how viruses orchestrate ER functions to infect cells","volume":"14","author":"Ravindran","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b0985","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12929-020-0618-6","article-title":"Endoplasmic reticulum: a focal point of Zika virus infection","volume":"27","author":"Mohd Ropidi","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bmc.2021.116356_b0990","doi-asserted-by":"crossref","unstructured":"Courageot M-P, Frenkiel M-P, Duarte Dos Santos C, Deubel V, Despr\u00e8s P. \u03b1-Glucosidase Inhibitors Reduce Dengue Virus Production by Affecting the Initial Steps of Virion Morphogenesis in the Endoplasmic Reticulum. J Virol. 2000;74(1):564 LP - 572. doi:10.1128\/JVI.74.1.564-572.2000.","DOI":"10.1128\/JVI.74.1.564-572.2000"},{"key":"10.1016\/j.bmc.2021.116356_b0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104881","article-title":"Iminosugars: A host-targeted approach to combat Flaviviridae infections","volume":"184","author":"Evans DeWald","year":"2020","journal-title":"Antiviral Res."},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b1000","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/v8090255","article-title":"Arms Race between Enveloped Viruses and the Host ERAD Machinery","volume":"8","author":"Frabutt","year":"2016","journal-title":"Viruses."},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b1005","article-title":"Role of the early secretory pathway in SARS-CoV-2 infection","volume":"219","author":"Sicari","year":"2020","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.bmc.2021.116356_b1010","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim Biophys Acta - Gen Subj."},{"key":"10.1016\/j.bmc.2021.116356_b1015","doi-asserted-by":"crossref","unstructured":"Bayer K, Banning C, Bruss V, Wiltzer-Bach L, Schindler M. Hepatitis C Virus Is Released via a Noncanonical Secretory Route. Ou J-HJ, ed. J Virol. 2016;90(23):10558 LP - 10573. doi:10.1128\/JVI.01615-16.","DOI":"10.1128\/JVI.01615-16"},{"key":"10.1016\/j.bmc.2021.116356_b1020","doi-asserted-by":"crossref","unstructured":"Inoue T, Tsai B. How viruses use the endoplasmic reticulum for entry, replication, and assembly. Cold Spring Harb Perspect Biol. 2013;5(1):a013250-a013250. doi:10.1101\/cshperspect.a013250.","DOI":"10.1101\/cshperspect.a013250"},{"issue":"15","key":"10.1016\/j.bmc.2021.116356_b1025","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.bmc.2021.116356_b1030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007949","article-title":"HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response","volume":"15","author":"Joyce","year":"2019","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1035","doi-asserted-by":"crossref","first-page":"38336","DOI":"10.1038\/srep38336","article-title":"STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-\u03bb but not by interferon-\u03b1","volume":"6","author":"Yamauchi","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b1040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT Pathway at Twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b1045","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.cellsig.2013.05.007","article-title":"Regulation of STAT signaling by acetylation","volume":"25","author":"Zhuang","year":"2013","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b1050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1101\/gad.1056303","article-title":"Protein ISGylation modulates the JAK-STAT signaling pathway","volume":"17","author":"Malakhova","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.bmc.2021.116356_b1055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2016.04.003","article-title":"The implication of SUMO in intrinsic and innate immunity","volume":"29","author":"Hannoun","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108234","article-title":"Evasion of Type I Interferon by SARS-CoV-2","volume":"33","author":"Xia","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bmc.2021.116356_b1065","doi-asserted-by":"crossref","unstructured":"Kumar S, Nyodu R, Maurya VK, Saxena SK. Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection BT - Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. In: Saxena SK, ed. Singapore: Springer Singapore; 2020:43-53. doi:10.1007\/978-981-15-4814-7_5.","DOI":"10.1007\/978-981-15-4814-7_5"},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.bmc.2021.116356_b1075","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/14712598.2020.1807001","article-title":"Host-directed therapies: a potential solution to combat COVID-19","volume":"20","author":"Baindara","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b1080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/joim.13144","article-title":"Cytokine storm syndrome in coronavirus disease 2019: A narrative review","volume":"289","author":"Gao","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bmc.2021.116356_b1085","doi-asserted-by":"crossref","unstructured":"Spiegel M, Pichlmair A, Mart\u00ednez-Sobrido L, et al. Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3. J Virol. 2005;79(4):2079 LP - 2086. doi:10.1128\/JVI.79.4.2079-2086.2005.","DOI":"10.1128\/JVI.79.4.2079-2086.2005"},{"key":"10.1016\/j.bmc.2021.116356_b1090","doi-asserted-by":"crossref","unstructured":"Kindler E, Thiel V, Weber F. Chapter Seven - Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response. In: Ziebuhr JBT-A in VR, ed. Coronaviruses. Vol 96. Academic Press; 2016:219-243. doi:https:\/\/doi.org\/10.1016\/bs.aivir.2016.08.006.","DOI":"10.1016\/bs.aivir.2016.08.006"},{"key":"10.1016\/j.bmc.2021.116356_b1095","doi-asserted-by":"crossref","unstructured":"Kopecky-Bromberg SA, Mart\u00ednez-Sobrido L, Frieman M, Baric RA, Palese P. Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists. J Virol. 2007;81(2):548 LP - 557. doi:10.1128\/JVI.01782-06.","DOI":"10.1128\/JVI.01782-06"},{"issue":"11","key":"10.1016\/j.bmc.2021.116356_b1100","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.4014\/jmb.1910.10014","article-title":"Chikungunya Virus-Encoded nsP2, E2 and E1 Strongly Antagonize the Interferon-&beta","volume":"29","author":"Bae","year":"2019","journal-title":"Signaling Pathway. J Microbiol Biotechnol."},{"key":"10.1016\/j.bmc.2021.116356_b1105","doi-asserted-by":"crossref","unstructured":"Simmons JD, Wollish AC, Heise MT. A Determinant of Sindbis Virus Neurovirulence Enables Efficient Disruption of Jak\/STAT Signaling. J Virol. 2010;84(21):11429 LP - 11439. doi:10.1128\/JVI.00577-10.","DOI":"10.1128\/JVI.00577-10"},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b1110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ni.3393","article-title":"A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity","volume":"17","author":"Chan","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bmc.2021.116356_b1115","doi-asserted-by":"crossref","unstructured":"A. DN, Velasco C, R. ME, J. BM. Dengue Virus NS Proteins Inhibit RIG-I\/MAVS Signaling by Blocking TBK1\/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant. MBio. 2021;6(3):e00553-15. doi:10.1128\/mBio.00553-15.","DOI":"10.1128\/mBio.00553-15"},{"key":"10.1016\/j.bmc.2021.116356_b1120","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3389\/fmicb.2018.01350","article-title":"Zika Virus Non-structural Protein 4A Blocks the RLR-MAVS Signaling","volume":"9","author":"Ma","year":"2018","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b1125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.chom.2019.09.012","article-title":"Zika Virus NS3 Mimics a Cellular 14\u20133-3-Binding Motif to Antagonize RIG-I- and MDA5-Mediated Innate Immunity","volume":"26","author":"Riedl","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bmc.2021.116356_b1130","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Jord\u00e1n JL, S\u00e1nchez-Burgos GG, Laurent-Rolle M, Garc\u00eda-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci. 2003;100(24):14333 LP - 14338. doi:10.1073\/pnas.2335168100.","DOI":"10.1073\/pnas.2335168100"},{"key":"10.1016\/j.bmc.2021.116356_b1135","doi-asserted-by":"crossref","unstructured":"Laurent-Rolle M, Boer EF, Lubick KJ, et al. The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling. J Virol. 2010;84(7):3503 LP - 3515. doi:10.1128\/JVI.01161-09.","DOI":"10.1128\/JVI.01161-09"},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b1140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1471-4906(03)00065-6","article-title":"Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection","volume":"24","author":"Suhrbier","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bmc.2021.116356_b1145","doi-asserted-by":"crossref","first-page":"29201","DOI":"10.1038\/srep29201","article-title":"Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses","volume":"6","author":"Flipse","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/088282403763635465","article-title":"Antibody-Dependent Enhancement of Virus Infection and Disease","volume":"16","author":"Tirado","year":"2003","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1155","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1160","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/celldisc.2017.6","article-title":"Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro","volume":"3","author":"Wu","year":"2017","journal-title":"Cell Discov."},{"key":"10.1016\/j.bmc.2021.116356_b1165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virol.2018.11.009","article-title":"Zika virus NS5 protein antagonizes type I interferon production via blocking TBK1 activation","volume":"527","author":"Lin","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.bmc.2021.116356_b1170","doi-asserted-by":"crossref","unstructured":"Ashour J, Laurent-Rolle M, Shi P-Y, Garc\u00eda-Sastre A. NS5 of Dengue Virus Mediates STAT2 Binding and Degradation. J Virol. 2009;83(11):5408 LP - 5418. doi:10.1128\/JVI.02188-08.","DOI":"10.1128\/JVI.02188-08"},{"key":"10.1016\/j.bmc.2021.116356_b1175","doi-asserted-by":"crossref","unstructured":"Angler\u00f3-Rodr\u00edguez YI, Pantoja P, Sariol CA. Dengue Virus Subverts the Interferon Induction Pathway via NS2B\/3 Protease-I\u03baB Kinase \u03b5 Interaction. Waters WR, ed. Clin Vaccine Immunol. 2014;21(1):29 LP - 38. doi:10.1128\/CVI.00500-13.","DOI":"10.1128\/CVI.00500-13"},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-018-0168-0","article-title":"Dengue virus and the host innate immune response","volume":"7","author":"Uno","year":"2018","journal-title":"Emerg Microbes Infect."},{"key":"10.1016\/j.bmc.2021.116356_b1185","doi-asserted-by":"crossref","unstructured":"Ye J, Chen Z, Li Y, et al. Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-\u03baB. Perlman S, ed. J Virol. 2017;91(8):e00039-17. doi:10.1128\/JVI.00039-17.","DOI":"10.1128\/JVI.00039-17"},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b1190","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12737","article-title":"Inhibition of type I interferon induction and signalling by mosquito-borne flaviviruses","volume":"19","author":"Cumberworth","year":"2017","journal-title":"Cell. Microbiol."},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b1195","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chom.2014.07.015","article-title":"The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon","volume":"16","author":"Laurent-Rolle","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.bmc.2021.116356_b1200","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2217\/fvl.14.70","article-title":"Novel drugs targeting Toll-like receptors for antiviral therapy","volume":"9","author":"Patel","year":"2014","journal-title":"Future Virol."},{"key":"10.1016\/j.bmc.2021.116356_b1205","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines: 1987\u20132017 and beyond","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antiviral Res."},{"issue":"12","key":"10.1016\/j.bmc.2021.116356_b1210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms131216785","article-title":"Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus","volume":"13","author":"Johari","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1215","doi-asserted-by":"crossref","first-page":"31777","DOI":"10.1038\/srep31777","article-title":"Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets","volume":"6","author":"Rojas","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bmc.2021.116356_b1220","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107245","article-title":"Interferon-inducer antivirals: Potential candidates to combat COVID-19","volume":"91","author":"Bagheri","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bmc.2021.116356_b1225","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139296","article-title":"Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus","volume":"131","author":"Vlahava","year":"2021","journal-title":"J Clin Invest."},{"issue":"10","key":"10.1016\/j.bmc.2021.116356_b1230","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tim.2015.07.005","article-title":"Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?","volume":"23","author":"Pelegrin","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bmc.2021.116356_b1235","doi-asserted-by":"crossref","unstructured":"Fukasawa M, Nagase S, Shirasago Y, et al. Monoclonal Antibodies against Extracellular Domains of Claudin-1 Block Hepatitis C Virus Infection in a Mouse Model. Ou J-HJ, ed. J Virol. 2015;89(9):4866 LP - 4879. doi:10.1128\/JVI.03676-14.","DOI":"10.1128\/JVI.03676-14"},{"key":"10.1016\/j.bmc.2021.116356_b1240","unstructured":"Davis CA. The role of Claudin-CD81 Co-Receptor interaction(s) in Hepatitis C virus entry. 2011."},{"issue":"2","key":"10.1016\/j.bmc.2021.116356_b1245","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06158","article-title":"Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19","volume":"7","author":"Patel","year":"2021","journal-title":"Heliyon."},{"key":"10.1016\/j.bmc.2021.116356_b1250","doi-asserted-by":"crossref","unstructured":"Westendorf K, \u017dentelis S, Foster D, et al. LY-CoV1404 potently neutralizes SARS-CoV-2 variants. bioRxiv. January 2021:2021.04.30.442182. doi:10.1101\/2021.04.30.442182.","DOI":"10.1101\/2021.04.30.442182"},{"issue":"3","key":"10.1016\/j.bmc.2021.116356_b1255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cei.13159","article-title":"Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH","volume":"193","author":"Ilan","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.bmc.2021.116356_b1260","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/hep.27196","article-title":"Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents","volume":"60","author":"Vercauteren","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1265","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2013.03.020","article-title":"Curing a viral infection by targeting the host: The example of cyclophilin inhibitors","volume":"99","author":"Lin","year":"2013","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1270","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12967-020-02476-9","article-title":"A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals","volume":"18","author":"Chitalia","year":"2020","journal-title":"J Transl Med."},{"key":"10.1016\/j.bmc.2021.116356_b1275","article-title":"Alisporivir plus Ribavirin achieves high rates of sustained HCV clearance (SVR24) as interferon (IFN)-free or IFN-add-on regimen in treatment-naive patients with HCV GT2 or GT3: Final results from VITAL-1 study: 233","volume":"56","author":"Pawlotsky","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bmc.2021.116356_b1280","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.antiviral.2014.02.008","article-title":"What are the pros and cons of the use of host-targeted agents against hepatitis C?","volume":"105","author":"Pawlotsky","year":"2014","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.bmc.2021.116356_b1285","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1039\/C4NP00085D","article-title":"Antiviral drug discovery: Broad-spectrum drugs from nature","volume":"32","author":"Martinez","year":"2015","journal-title":"Nat. Prod. Rep."},{"issue":"6","key":"10.1016\/j.bmc.2021.116356_b1290","article-title":"Fluvastatin Inhibits Hepatitis C Replication in Humans","volume":"103","author":"Bader","year":"2008","journal-title":"Off. J. Am. Coll. Gastroenterol|ACG."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:14:52Z","timestamp":1760836492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621003643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":258,"alternative-id":["S0968089621003643"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116356","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116356"}}